Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on …

MN Uddin, R Akter, M Li, Z Abdelrahman - Chemico-Biological Interactions, 2021 - Elsevier
The aberrant expression level of SARS-CoV-2 cell receptor gene ACE2 was reported in lung
adenocarcinoma (LUAD) comorbidity of COVID-19. However, the association of ACE2 …

[HTML][HTML] Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational …

A Samad, T Jafar, JH Rafi - Genomics, 2020 - Elsevier
COVID-19 is a pandemic that began to spread worldwide caused by SARS-CoV-2. Lung
cancer patients are more susceptible to SARS-CoV-2 infection. The SARS-CoV-2 enters into …

The landscape of coronavirus disease 2019 (COVID-19) and integrated analysis SARS-CoV-2 receptors and potential inhibitors in lung adenocarcinoma patients

B Tang, J Zhu, Y Cong, W Yang, C Kong… - Frontiers in Cell and …, 2020 - frontiersin.org
The outbreak of novel coronavirus disease 2019 (COVID-19) has become the largest health
threat worldwide, with more than 34.40 million positive cases and over 1.02 million deaths …

[HTML][HTML] Expression of the SARS-CoV-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer

H Zhang, K Quek, R Chen, J Chen, B Chen - Journal of Cancer, 2020 - ncbi.nlm.nih.gov
Recent studies have revealed that cancer patients had a higher risk of having coronavirus
disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 …

[HTML][HTML] Evaluation of the susceptibility and fatality of lung cancer patients towards the COVID-19 infection: A systemic approach through analyzing the ACE2, CXCL10 …

TB Mahmood, AS Chowdhury, MU Hossain… - Current research in …, 2021 - Elsevier
Abstract Coronavirus disease-2019 (COVID-19) is a recent world pandemic disease that is
caused by a newly discovered strain of the Severe Acute Respiratory Syndrome …

Systematic profiling of ACE2 expression in diverse physiological and pathological conditions for COVID‐19/SARS‐CoV‐2

Y Li, Q Xu, L Ma, D Wu, J Gao… - Journal of cellular and …, 2020 - Wiley Online Library
Recent retrospective studies of severe acute respiratory syndrome coronavirus 2 (SARS‐
CoV‐2) disease (COVID‐19) revealed that the patients with common comorbidities of …

[HTML][HTML] A profiling analysis on the receptor ACE2 expression reveals the potential risk of different type of cancers vulnerable to SARS-CoV-2 infection

YJ Dai, F Hu, H Li, HY Huang, DW Wang… - Annals of translational …, 2020 - ncbi.nlm.nih.gov
Background The new coronavirus pneumonia (NCP) is now causing a severe public health
emergency. The novel coronavirus 2019 (2019-nCoV) infected individuals by binding …

[HTML][HTML] The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression

Z Zhang, L Li, M Li, X Wang - Computational and structural biotechnology …, 2020 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than
29 million people and has caused more than 900,000 deaths worldwide as of September …

[HTML][HTML] Bioinformatic analysis of correlation between immune infiltration and COVID-19 in cancer patients

X Huang, C He, X Hua, A Kan, S Sun… - International Journal of …, 2020 - ncbi.nlm.nih.gov
In 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused
infections worldwide. However, the correlation between the immune infiltration and …

Systematic analysis of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignant tumors: pan-cancer analysis

J Song, J Han, F Liu, X Chen, S Qian… - Frontiers in Molecular …, 2020 - frontiersin.org
Background Coronavirus disease 2019 (COVID-19) was first detected in patients with
pneumonia in December 2019 in China and it spread rapidly to the rest of the world …